Skip to content
2000
Volume 28, Issue 2
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

The COVID-19 pandemic continues to wreak havoc worldwide due to the lack of risk assessment, rapid spreading ability, and propensity to precipitate severe disease in comorbid conditions. In an attempt to fulfill the demand for prophylactic and treatment measures to intercept the ongoing outbreak, the drug development process is facing several obstacles and renaissance in clinical trials, including vaccines, antivirals, immunomodulators, plasma therapy, and traditional medicines. This review outlines the overview of SARS-CoV-2 infection, significant recent findings, and ongoing clinical trials concerning current and future therapeutic interventions for the management of advancing pandemic of the century.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867327666200908113642
2021-01-01
2024-11-07
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867327666200908113642
Loading
  • Article Type: Review Article
Keyword(s): Convalescent Plasma; COVID-19; Cytokine Storm; Remdesivir; SARS-CoV-2; TCM; Vaccines
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test